Biomarin Pharmaceutical Inc Stock Ownership - Who owns Biomarin Pharmaceutical?

Insider buying vs selling

Have Biomarin Pharmaceutical Inc insiders been buying or selling?
Henry J. FuchsPresident Worldwide RD2023-03-1636,000$93.41
Jean Jacques BienaimeChief Executive Officer2023-03-1688,623$93.41
George Eric DavisEVP Chief Legal Officer2023-03-1619,957$93.41
Jeffrey Robert AjerEVP Chief Commercial Officer2023-03-1620,510$93.41
Brian MuellerEVP Chief Financial Officer2023-03-163,973$93.41
Jeffrey Robert AjerEVP Chief Commercial Officer2023-03-153,971$87.74
Henry J. FuchsPresident Worldwide RD2023-03-154,799$87.74
Jean Jacques BienaimeChief Executive Officer2023-03-159,437$87.74
Brian MuellerEVP Chief Financial Officer2023-03-152,708$87.74
Charles Greg GuyerEVP Chief Technical Officer2023-03-151,856$87.74

1 of 11

BMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRN insiders and whales buy or sell their stock.

BMRN Shareholders

What type of owners hold Biomarin Pharmaceutical Inc stock?
Primecap Management Co9.43%17,580,859$1.61BInstitution
Vanguard Group Inc9.31%17,365,080$1.59BInstitution
Blackrock Inc7.80%14,540,191$1.33BInstitution
Dodge Cox7.71%14,383,663$1.32BInstitution
Baker Bros Advisors LP4.09%7,620,494$698.57MInstitution
Capital Research Global Investors3.03%5,651,001$518.03MInstitution
State Street Corp2.89%5,388,844$494.00MInstitution
Viking Global Investors LP2.83%5,273,620$483.43MInstitution
Ameriprise Financial Inc2.49%4,648,628$426.14MInstitution
Janus Henderson Group PLC2.08%3,888,444$356.45MInstitution

1 of 3

BMRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRN97.63%1.50%Net SellingNet Selling
INCY78.83%21.17%Net SellingNet Buying
RPRX48.68%16.47%Net SellingNet Selling
SRPT73.25%26.75%Net BuyingNet Selling

Biomarin Pharmaceutical Stock Ownership FAQ

Who owns Biomarin Pharmaceutical?

Biomarin Pharmaceutical (NASDAQ: BMRN) is owned by 97.63% institutional shareholders, 1.50% Biomarin Pharmaceutical insiders, and 0.87% retail investors. Primecap Management Co is the largest individual Biomarin Pharmaceutical shareholder, owning 17.58M shares representing 9.43% of the company. Primecap Management Co's Biomarin Pharmaceutical shares are currently valued at $1.62B.

If you're new to stock investing, here's how to buy Biomarin Pharmaceutical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.